| Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
| Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
| Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[2] Vaginal discharge syndrome – Sexual activity criterion: National Institute for Communicable Diseases. Report on the Sentinel Surveillance of Sexually Transmitted Infection Syndrome Aetiologies and HPV Genotypes among Patients attending Public Health Facilities in South Africa (April 2014 – September 2015), embargoed, to be published.
Vaginal discharge syndrome – speculum examination: National Department of Health. Comprehensive STI Clinical Management Guidelines, draft version.
Clotrimazole, topical: Vaginal discharge syndrome – non-sexually active women (monotherapy syndromic directed management – candidiasis): National Institute for Communicable Diseases. Report on the Sentinel Surveillance of Sexually Transmitted Infection Syndrome Aetiologies and HPV Genotypes among Patients attending Public Health Facilities in South Africa (April 2014 – September 2015), embargoed, to be published.
Metronidazole, oral: Vaginal discharge syndrome – non-sexually active women (monotherapy syndromic directed management – bacterial vaginosis): National Institute for Communicable Diseases. Report on the Sentinel Surveillance of Sexually Transmitted Infection Syndrome Aetiologies and HPV Genotypes among Patients attending Public Health Facilities in South Africa (April 2014 – September 2015), embargoed, to be published.